• Mon. Jan 24th, 2022

Covid, ok WHO for emergency use of the Chinese vaccine

Byeditorial

Jun 1, 2021

WHO has approved the Sinovac-CoronaVac Covid vaccine for emergency use, assuring countries, financiers, procurement agencies and communities that the Chinese pharmaceutical Sinovac’s product “meets international standards for safety, efficacy and manufacturing.” “The world is in desperate need of more vaccines against Covid-19 to tackle the enormous inequality of access on the planet – comments Mariângela Simão, WHO manager for access to health products – We urge manufacturers to participate in the Covax program, share the their know-how and their data and help keep the pandemic under control “.

One thought on “Covid, ok WHO for emergency use of the Chinese vaccine”
  1. editorial says:

    https://created.crayola.com/network/members/profile?UserKey=1bb702c8-0426-4236-97a9-b5f5b687d529
    https://created.crayola.com/network/members/profile?UserKey=4c5e99d6-2585-47ff-8425-e5ebb7d9caa5
    https://created.crayola.com/network/members/profile?UserKey=6642df9b-8012-47b2-8dfb-4e2fceab652d
    https://created.crayola.com/network/members/profile?UserKey=54e552f1-0e46-4502-bef5-42fb3d535e70
    https://created.crayola.com/network/members/profile?UserKey=fe32f736-7aef-456b-a19e-d5c4740077fd
    https://created.crayola.com/network/members/profile?UserKey=19bd3fef-f08b-4527-b917-4f74fc0b1b13
    https://created.crayola.com/network/members/profile?UserKey=a4b66b30-e17f-482a-8994-405e39c0acb1
    https://created.crayola.com/network/members/profile?UserKey=3b42d863-1a76-4258-a91f-e404419eb033
    https://created.crayola.com/network/members/profile?UserKey=24d7ae87-3a33-4fe1-ad8a-4d4a1b5a70ac
    https://connect.informs.org/network/members/profile?UserKey=2d5f91b3-5592-4c71-844d-0892a7993ebb
    https://connect.informs.org/network/members/profile?UserKey=47865a51-9cc1-438a-816d-4404a7c703e1
    https://connect.informs.org/network/members/profile?UserKey=7f63c207-65e8-4481-9df3-a13023ab61ba
    https://connect.informs.org/network/members/profile?UserKey=0fd439c2-1c4b-49da-964f-cb70c57f03d1
    https://connect.informs.org/network/members/profile?UserKey=00b64d75-624a-43c4-850c-02889a3863ec
    https://connect.informs.org/network/members/profile?UserKey=0dacf872-faca-4c24-8914-ee00b572e98f
    https://connect.informs.org/network/members/profile?UserKey=4657ef3b-aa36-47c0-bf7d-f1c8f81c0dd8
    https://connect.informs.org/network/members/profile?UserKey=0de75301-eb46-4447-9775-fd8baa8783e3
    https://connect.informs.org/network/members/profile?UserKey=d6de3bc1-5c5d-42d4-bbf9-b9ee68abf152
    https://connect.informs.org/network/members/profile?UserKey=88de7a11-681e-44f4-8573-5f11a515b741
    https://connect.informs.org/network/members/profile?UserKey=723b2673-a784-4bbc-aa11-42ed073bf68d
    https://connect.informs.org/network/members/profile?UserKey=f9be8d8c-529c-4533-a578-cf425530d6ed
    https://connect.informs.org/network/members/profile?UserKey=60961d91-48b8-4edb-9e0d-014a7db18e17
    https://connect.informs.org/network/members/profile?UserKey=e98f002d-13ae-43d6-a412-a0b0b0117cdb
    https://connect.informs.org/network/members/profile?UserKey=81db40a8-5656-4cae-abae-15de7841deba
    https://connect.informs.org/network/members/profile?UserKey=1dee85ce-5de7-4722-bd8a-64be8348d36f
    https://connect.informs.org/network/members/profile?UserKey=4a687712-1654-4fad-af29-23bc8234ed34
    https://connect.informs.org/network/members/profile?UserKey=8b48e7e8-65ae-485f-9366-bfed68067d4e
    https://connect.informs.org/network/members/profile?UserKey=10fcdabb-982b-4119-9101-cfe5de088441
    https://connect.informs.org/network/members/profile?UserKey=8052e533-a29d-4da0-839b-68f0d60c2064
    https://connect.informs.org/network/members/profile?UserKey=0c20614d-a339-40c4-b639-660cf68038fa
    https://connect.informs.org/network/members/profile?UserKey=a095f84f-7aa0-420d-8cd0-6e3be0448fc8
    https://connect.informs.org/network/members/profile?UserKey=e95de17b-362f-4721-b8ee-1687ee55c5fa
    https://connect.informs.org/network/members/profile?UserKey=c7af1fea-981c-490f-b637-978d8d7f5f18
    https://connect.informs.org/network/members/profile?UserKey=127c9db2-f3f0-4163-8a69-4ea7c6d2a504
    https://connect.informs.org/network/members/profile?UserKey=7bc2b749-fb38-4402-96ef-db9014d25836
    https://connect.informs.org/network/members/profile?UserKey=2621870c-c2e3-4a17-bfdc-dcecb962be35
    https://connect.informs.org/network/members/profile?UserKey=31850561-e56f-44f4-81de-692f7bae32a2
    https://connect.informs.org/network/members/profile?UserKey=4d88a90d-79fc-4fc6-85cf-af7854ba28f2
    https://connect.informs.org/network/members/profile?UserKey=219d9b9b-230b-4f5d-b2ee-fc02637c7464
    https://connect.informs.org/network/members/profile?UserKey=573f083a-f768-46e5-9512-82249327aa1e
    https://connect.informs.org/network/members/profile?UserKey=f9913fa6-833c-4bc4-9cee-71c688deaf57
    https://connect.informs.org/network/members/profile?UserKey=b4bd25a2-70d8-4eb7-ad16-bd650a6b2248
    https://connect.informs.org/network/members/profile?UserKey=b5d37f44-b26f-4b3f-8864-20800119c933
    https://connect.informs.org/network/members/profile?UserKey=453add00-9c04-42a5-af3e-de53c4896cb2
    https://connect.informs.org/network/members/profile?UserKey=c3ec3cd5-8448-4092-804d-89c45b847356
    https://connect.informs.org/network/members/profile?UserKey=6421c521-f7be-4ed3-8520-61a0bd739ac5
    https://connect.informs.org/network/members/profile?UserKey=86435865-2d0b-4239-b9bc-35abe405ecdb
    https://connect.informs.org/network/members/profile?UserKey=cf410941-501d-4a9d-a822-c22c325ad4fe
    https://connect.informs.org/network/members/profile?UserKey=d90e6425-a129-4fe3-88e6-09a3c1ccd1e6
    https://connect.informs.org/network/members/profile?UserKey=529a96cd-3977-4700-b2e2-e47e8bfc2806

Comments are closed.